This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025. “It does raise significant issues about whether small practices and small institutions can effectively protect patient privacy in the new age we’re living in.
With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. In 2025, AI-powered marketing tools and programmatic ad placements are driving efficiency and targeting precision.
Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. As automation becomes smarter, ensuring HIPAA and GDPR compliance remains critical. However, marketers must balance innovation with privacy.
The world of pharma marketing is changing rapidly, and 2025 will be no exception. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? Data Privacy and Compliance Challenges Data privacy is one of the most pressing concerns in 2025, especially with new regulations being enacted globally.
In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. In 2025, digital channels dominate marketing strategies as companies shift from traditional campaigns to online platforms. What are the biggest challenges in pharma marketing in 2025?
As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. As we move towards 2025, regulatory bodies are increasingly focusing on transparency, patient privacy, and ethical marketing practices.
This guide explores essential strategies to ensure your team is prepared for the shifting dynamics of healthcare marketing in 2025 and beyond. Regulatory frameworks such as HIPAA, GDPR, and FDA guidelines dictate how pharmaceutical brands can advertise and engage with healthcare professionals (HCPs) and patients.
According to the Deloitte report , the volume of health data rose by 40% between 2010 and 2020 and is predicted to climb even higher by 23% by 2025. Our solutions comply with GDPR, HIPAA, and numerous other industry standards. Pharma companies deal with enormous amounts of health data.
billion by 2025 , with a compound annual growth rate (CAGR) growth of more than 9%. Such sensitive data inside healthcare CRM software should be stored according to HIPAA compliance. Such a massive number of patients require a more advanced approach regarding patient relationships and how to manage them. Let’s go.
Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3. Global Strategy on Digital Health 2020-2025.” 2022.2040.
In the case of a remote temperature monitoring example, processes need to be in place for managing HIPAA and general data protection regulation (GDPR) requirements for the product as required. Global Strategy on Digital Health 2020-2025.” 37 Med-Tech News. FDA Grants Breakthrough Designation for Novel Heart Monitor.” Acknowledgments.
Second, data privacy regulations like HIPAA, GDPR, and updates to third-party cookie policies are pushing marketers to invest in first-party data and secure platforms. What skills should pharma marketing teams develop in 2025? According to recent industry insights, 70% of HCPs prefer digital touchpoints over traditional rep visits.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content